Edwards Lifesciences Financial Overview
Edwards Lifesciences's market cap is currently $48.21B. The company's EPS TTM is $0.67; its P/E ratio is 35.50; Edwards Lifesciences is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $0.62. See an overview of income statement, balance sheet, and cash flow financials.
